<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Pfizer&#8217;s Jeff Kindler Gets A Hefty Raise</title>
	<atom:link href="http://www.pharmalot.com/2010/03/pfizers-jeff-kindler-gets-a-hefty-raise/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2010/03/pfizers-jeff-kindler-gets-a-hefty-raise/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 21:54:38 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Pharma Giles</title>
		<link>http://www.pharmalot.com/2010/03/pfizers-jeff-kindler-gets-a-hefty-raise/#comment-474830</link>
		<dc:creator>Pharma Giles</dc:creator>
		<pubDate>Thu, 04 Mar 2010 22:04:46 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=21774#comment-474830</guid>
		<description>Honestly, what a fuss over a lousy 12.5%.  Now &lt;a href="http://business.timesonline.co.uk/tol/business/industry_sectors/health/article7041861.ece" rel="nofollow"&gt;THIS&lt;/a&gt; is what I call a pay rise...</description>
		<content:encoded><![CDATA[<p>Honestly, what a fuss over a lousy 12.5%.  Now <a href="http://business.timesonline.co.uk/tol/business/industry_sectors/health/article7041861.ece" rel="nofollow">THIS</a> is what I call a pay rise&#8230;</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Casual Observer</title>
		<link>http://www.pharmalot.com/2010/03/pfizers-jeff-kindler-gets-a-hefty-raise/#comment-474796</link>
		<dc:creator>Casual Observer</dc:creator>
		<pubDate>Thu, 04 Mar 2010 15:59:56 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=21774#comment-474796</guid>
		<description>You forgot about the billions in fines that Pfizer has had to pay on his watch!  I think there's been a lot of off-label promotion and questionable marketing going on at the big P for many years.  Isn't Kindler a lawyer?  Shouldn't he know better?</description>
		<content:encoded><![CDATA[<p>You forgot about the billions in fines that Pfizer has had to pay on his watch!  I think there&#8217;s been a lot of off-label promotion and questionable marketing going on at the big P for many years.  Isn&#8217;t Kindler a lawyer?  Shouldn&#8217;t he know better?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Former Big Pharma</title>
		<link>http://www.pharmalot.com/2010/03/pfizers-jeff-kindler-gets-a-hefty-raise/#comment-474794</link>
		<dc:creator>Former Big Pharma</dc:creator>
		<pubDate>Thu, 04 Mar 2010 15:51:18 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=21774#comment-474794</guid>
		<description>Wow!  Turn in a dismal performance, stagnate the company, slice R &#38; D, lay off thousands, destroy Wyeth, and get a huge raise.  What an absolute joke!  Hopefully, many of the self-loving, self-promoting, egomaniacs will soon be booted.</description>
		<content:encoded><![CDATA[<p>Wow!  Turn in a dismal performance, stagnate the company, slice R &amp; D, lay off thousands, destroy Wyeth, and get a huge raise.  What an absolute joke!  Hopefully, many of the self-loving, self-promoting, egomaniacs will soon be booted.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: clarkkent</title>
		<link>http://www.pharmalot.com/2010/03/pfizers-jeff-kindler-gets-a-hefty-raise/#comment-474782</link>
		<dc:creator>clarkkent</dc:creator>
		<pubDate>Thu, 04 Mar 2010 14:36:44 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=21774#comment-474782</guid>
		<description>PFE stock has underperformed the DOW the entire time Kindler has been CEO.  He should be getting a pay cut (or pfired,) not rewarded for subpar performance.</description>
		<content:encoded><![CDATA[<p>PFE stock has underperformed the DOW the entire time Kindler has been CEO.  He should be getting a pay cut (or pfired,) not rewarded for subpar performance.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Lisa Van Syckel</title>
		<link>http://www.pharmalot.com/2010/03/pfizers-jeff-kindler-gets-a-hefty-raise/#comment-474767</link>
		<dc:creator>Lisa Van Syckel</dc:creator>
		<pubDate>Thu, 04 Mar 2010 12:03:16 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=21774#comment-474767</guid>
		<description>Geee, one would wonder why he needed home securuty, could it be from those homucidal/suicidal zoloft patients?</description>
		<content:encoded><![CDATA[<p>Geee, one would wonder why he needed home securuty, could it be from those homucidal/suicidal zoloft patients?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Jack Friday</title>
		<link>http://www.pharmalot.com/2010/03/pfizers-jeff-kindler-gets-a-hefty-raise/#comment-474764</link>
		<dc:creator>Jack Friday</dc:creator>
		<pubDate>Thu, 04 Mar 2010 11:08:55 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=21774#comment-474764</guid>
		<description>Ahem!

http://pharmagossip.blogspot.com/search?q=kindler%27s+list

By yours truly in 2006!</description>
		<content:encoded><![CDATA[<p>Ahem!</p>
<p><a href="http://pharmagossip.blogspot.com/search?q=kindler%27s+list" rel="nofollow">http://pharmagossip.blogspot.com/search?q=kindler%27s+list</a></p>
<p>By yours truly in 2006!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: pharmavet</title>
		<link>http://www.pharmalot.com/2010/03/pfizers-jeff-kindler-gets-a-hefty-raise/#comment-474641</link>
		<dc:creator>pharmavet</dc:creator>
		<pubDate>Thu, 04 Mar 2010 01:05:21 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=21774#comment-474641</guid>
		<description>Over on CafePharma, Jeff's headcount reduction is affectionately termed "Kindler's List".</description>
		<content:encoded><![CDATA[<p>Over on CafePharma, Jeff&#8217;s headcount reduction is affectionately termed &#8220;Kindler&#8217;s List&#8221;.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Anne PME</title>
		<link>http://www.pharmalot.com/2010/03/pfizers-jeff-kindler-gets-a-hefty-raise/#comment-474634</link>
		<dc:creator>Anne PME</dc:creator>
		<pubDate>Thu, 04 Mar 2010 00:50:53 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=21774#comment-474634</guid>
		<description>Oh, and let's not forget the recent false claims settlement....Maybe part of the raise has to do with the fact that Pfizer now has a corporate intergrity panel that will further convolute board member and/or CEO liability?</description>
		<content:encoded><![CDATA[<p>Oh, and let&#8217;s not forget the recent false claims settlement&#8230;.Maybe part of the raise has to do with the fact that Pfizer now has a corporate intergrity panel that will further convolute board member and/or CEO liability?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: pharmavet</title>
		<link>http://www.pharmalot.com/2010/03/pfizers-jeff-kindler-gets-a-hefty-raise/#comment-474632</link>
		<dc:creator>pharmavet</dc:creator>
		<pubDate>Thu, 04 Mar 2010 00:47:16 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=21774#comment-474632</guid>
		<description>looking at PFE from an investor's perspective, Bruce Berkowitz, the highly successful manager of The Fairholme Fund (FAIRX) recently unloaded about 38 million shares pf PFE, which up to then was by far the largest holding in the FAIRX portfolio.  Bruce must know something.  He made people a lot of money by buying PFE a few years ago.  Based on his move, I wouldn't go long on PFE at this time.

Remember why Jeff Kindler was hired in the first place.  As a lawyer, his main job was to minimize PFE's legal exposure.  He has brought in some pretty heavy duty legal muscle to manage WYE'S issues with Prempro, etc.  A lot of this is behind the scenes, but these expenses go straight to the corporate bottom line.  To the extent that Jeff is successful in minimizing the legal damamages he will have earned his raise.  It just won't show up in the usual pharma metrics.</description>
		<content:encoded><![CDATA[<p>looking at PFE from an investor&#8217;s perspective, Bruce Berkowitz, the highly successful manager of The Fairholme Fund (FAIRX) recently unloaded about 38 million shares pf PFE, which up to then was by far the largest holding in the FAIRX portfolio.  Bruce must know something.  He made people a lot of money by buying PFE a few years ago.  Based on his move, I wouldn&#8217;t go long on PFE at this time.</p>
<p>Remember why Jeff Kindler was hired in the first place.  As a lawyer, his main job was to minimize PFE&#8217;s legal exposure.  He has brought in some pretty heavy duty legal muscle to manage WYE&#8217;S issues with Prempro, etc.  A lot of this is behind the scenes, but these expenses go straight to the corporate bottom line.  To the extent that Jeff is successful in minimizing the legal damamages he will have earned his raise.  It just won&#8217;t show up in the usual pharma metrics.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: JDP</title>
		<link>http://www.pharmalot.com/2010/03/pfizers-jeff-kindler-gets-a-hefty-raise/#comment-474595</link>
		<dc:creator>JDP</dc:creator>
		<pubDate>Wed, 03 Mar 2010 22:25:27 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=21774#comment-474595</guid>
		<description>This is part of the root of the problem - and Pfizer's Board should be smarter.  It is a mistake to give him a big reward for acquiring Wyeth and laying off a lot of people (thereby reducing costs and increasing profits).  This is only of short term benefit to Pfizer, and may actually be to its detriment.  His team should only be rewarded if, in 4-5 years, the merged company is better able to bring more and better medicines to the market.  If it is not, then he and his staff let the wrong people go, and they should be penalized.  When will boards learn to take a long view?</description>
		<content:encoded><![CDATA[<p>This is part of the root of the problem - and Pfizer&#8217;s Board should be smarter.  It is a mistake to give him a big reward for acquiring Wyeth and laying off a lot of people (thereby reducing costs and increasing profits).  This is only of short term benefit to Pfizer, and may actually be to its detriment.  His team should only be rewarded if, in 4-5 years, the merged company is better able to bring more and better medicines to the market.  If it is not, then he and his staff let the wrong people go, and they should be penalized.  When will boards learn to take a long view?</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.158 seconds -->

